CVS Health Corporation (CVS) Stock Analysis
A live, multi-source view of CVS Health Corporation (CVS): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans.
Sector: Healthcare · Industry: Healthcare Plans · United States · 219,000 employees · cvshealth.com
Key statistics · as of 2026-09-05
As of 2026-09-05, CVS Health Corporation (CVS) had a market capitalization of $123.73B, a trailing P/E of 25.7 (forward 11.4), a dividend yield of 2.74% and a beta of 0.58; the shares traded in a 52-week range of $69.51 – $110.68 (38.3% over the year).
- Market cap
- $123.73B
- Enterprise value
- $186.27B
- Trailing P/E
- 25.7
- Forward P/E
- 11.4
- PEG ratio
- 0.23
- Price / book
- 1.55
- EPS (trailing)
- $3.77
- EPS (forward)
- $8.51
- Dividend yield
- 2.74%
- Payout ratio
- 70.2%
- Ex-dividend date
- 2026-07-23
- 52-week range
- $69.51 – $110.68
- 52-week change
- 38.3%
- Beta
- 0.58
- Average volume
- 7.9M
- Shares outstanding
- 1.28B
- Short % of float
- 1.32%
- Profit margin
- 1.2%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, CVS Health Corporation (CVS) last closed at $95.29 (the last completed close before that scan).
Technicals at the scan: RSI 45 (neutral territory), price +0.4% versus its 20-day average, 20-day versus 50-day average spread -5.4%, MACD histogram 0.48.
Sentiment inputs: 83% of recent Finnhub-scored headlines read bullish; StockTwits 100% bullish; analyst consensus score 78/100.
Next scheduled company event: in 47 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 1 buy and 1 sell of CVS; corporate insiders filed 0 buys and 0 sells (2 distinct filers, latest disclosure 2026-08-05). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Tommy Tuberville (0B/1S), Alan Armstrong (1B/0S). Who is trading what
RapidTradeView pick record
CVS has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls CVS Health Corporation (CVS) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell CVS.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.